Publication
Outcomes of Parenchyma-Preserving Hepatectomy and Right Hepatectomy for Solitary Small Colorectal Liver Metastasis: A LiverMetSurvey Study
dc.contributor.author | Hosokawa, I | |
dc.contributor.author | Allard, MA | |
dc.contributor.author | Mirza, DF | |
dc.contributor.author | Kaiser, G | |
dc.contributor.author | Barroso, E | |
dc.contributor.author | Lapointe, R | |
dc.contributor.author | Laurent, C | |
dc.contributor.author | Ferrero, A | |
dc.contributor.author | Miyazaki, M | |
dc.contributor.author | Adam, R | |
dc.date.accessioned | 2019-03-20T16:42:33Z | |
dc.date.available | 2019-03-20T16:42:33Z | |
dc.date.issued | 2017 | |
dc.description.abstract | BACKGROUND: Occasionally, right hepatectomy, rather than parenchyma-preserving hepatectomy, has been performed for solitary small colorectal liver metastasis. The relative oncologic benefits of parenchyma-preserving hepatectomy and right hepatectomy are unclear. This study compared the outcomes of patients with solitary small colorectal liver metastasis in the right liver who underwent parenchyma-preserving hepatectomy and those who underwent right hepatectomy. METHODS: The study population consisted of a multicentric cohort of 21,072 patients operated for colorectal liver metastasis between 2000 and 2015 whose data were collected in the LiverMetSurvey registry. Patients with a pathologically confirmed solitary tumor of less than 30 mm in size in the right liver were included. The short- and long-term outcomes of patients who underwent parenchyma-preserving hepatectomy were compared to those of patients who underwent right hepatectomy. RESULTS: Of the 1,720 patients who were eligible for the study, 1,478 (86%) underwent parenchyma-preserving hepatectomy and 242 (14%) underwent right hepatectomy. The parenchyma-preserving hepatectomy group was associated with lower rates of major complications (3% vs 10%; P < .001) and 90-day mortality (1% vs 3%; P = .008). Liver recurrence occurred similarly in both groups (20% vs 22%; P = .39). The 5-year recurrence-free survival and overall survival rates were similar in both groups. However, in patients with liver-only recurrence, repeat hepatectomy was more frequently performed in the parenchyma-preserving hepatectomy group than in the right hepatectomy group (67% vs 31%; P < .001), and the overall 5-year survival rate was significantly higher in the parenchyma-preserving hepatectomy group than in the right hepatectomy group (55% vs 23%; P < .001). CONCLUSION: Parenchyma-preserving hepatectomy should be considered the standard procedure for solitary small colorectal liver metastasis in the right liver when technically feasible. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Surgery. 2017 Aug;162(2):223-232. | pt_PT |
dc.identifier.doi | 10.1016/j.surg.2017.02.012 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/3204 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Elsevier | pt_PT |
dc.subject | Aged | pt_PT |
dc.subject | Cohort Studies | pt_PT |
dc.subject | Colorectal Neoplasms | pt_PT |
dc.subject | Disease-Free Survival | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Hepatectomy | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Liver Neoplasms | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Middle Aged | pt_PT |
dc.subject | Neoplasm Recurrence, Local | pt_PT |
dc.subject | Survival Rate | pt_PT |
dc.subject | Treatment Outcome | pt_PT |
dc.subject | HCC CHBPT | pt_PT |
dc.title | Outcomes of Parenchyma-Preserving Hepatectomy and Right Hepatectomy for Solitary Small Colorectal Liver Metastasis: A LiverMetSurvey Study | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 232 | pt_PT |
oaire.citation.issue | 2 | pt_PT |
oaire.citation.startPage | 223 | pt_PT |
oaire.citation.title | Surgery | pt_PT |
oaire.citation.volume | 162 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |